tiprankstipranks
Ehealth (EHTH)
NASDAQ:EHTH
US Market
Want to see EHTH full AI Analyst Report?

Ehealth (EHTH) Earnings Dates, Call Summary & Reports

1,038 Followers

Earnings Data

Report Date
Aug 12, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.84
Last Year’s EPS
-1.26
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 06, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call balanced near-term execution challenges with clear progress on unit economics, cost reductions and strategic product/operating-model initiatives. While revenue and submissions declined materially year-over-year and GAAP results swung to a loss due to restructuring and timing, management highlighted improved Medicare LTV-to-CAC (1.4x, +17%), wider Medicare gross margins (34% to 41%), reduced marketing spend with lower CAC, a positive adjusted EBITDA ($9M) and a plan to achieve breakeven free cash flow in 2027. The team framed 2026 as an intentional, cash-flow-focused bridge year and provided a 3-year outlook targeting margin expansion and revenue growth, supported by the lifetime advisory model and ancillary product cross-sell. On balance, the operational improvements, cost actions and a credible multi-year plan offset the near-term declines.
Company Guidance
Management maintained its 2026 guidance ranges for revenue, GAAP net income, adjusted EBITDA and operating cash flow while updating net adjustment (tail) revenue to $8M–$20M and positioning 2026 as a bridge year focused on achieving breakeven-or-better operating cash flow and setting the company up for breakeven-or-better free cash flow in 2027. The refreshed three‑year outlook calls for mid‑single‑digit revenue growth in 2027 and mid‑teens in 2028, double‑digit adjusted EBITDA growth in 2027–28 and adjusted EBITDA margin expansion to ~20% by 2028, assuming flat tail revenue in the outer years and a modest uptick in Medicare marketing in Q4 2027. Key drivers include an expected ~$30M fixed cost reduction in 2026 (roughly a 20% cut), greater contribution from ancillary sales and future ICHRA revenue, and continued focus on higher‑quality enrollments. The plan is supported by Q1 results of $88M revenue, $4.7M GAAP net loss, $9M adjusted EBITDA (10% margin), $35.8M operating cash flow, $110.8M cash and equivalents, Medicare LTV improvements (MA +3%, MedSupp +19%, PDP +78%), a 10% decline in total acquisition cost per MA‑equivalent approved member and a 28% decline in variable marketing cost per MA‑equivalent approved member.
Revenue Ahead of Expectations
First quarter 2026 revenue of $88.0 million came in ahead of company expectations despite year-over-year pressure; management emphasized quality over volume for 2026.
Improved Medicare Unit Economics
Medicare LTV to CAC ratio improved to 1.4x, a 17% improvement from 1.2x a year ago; Medicare MA LTV increased 3% year-over-year and total acquisition cost per MA equivalent approved member declined 10%.
Lowered Variable Marketing Costs and Better Channel Mix
Variable marketing cost per MA equivalent approved member declined 28%; non-GAAP marketing & advertising expense declined 38% (variable marketing down 44%), reflecting disciplined demand generation and a shift toward higher-quality branded channels.
Margin Expansion in Medicare Segment
Medicare segment gross profit was $33 million (down 8% YoY), but gross profit margin widened materially from 34% to 41%, driven by improved LTV-to-CAC and higher-quality enrollments.
Adjusted EBITDA and Positive Operating Cash Flow Start
First quarter adjusted EBITDA was $9.0 million (exceeding internal plan) and operating cash flow was positive at $35.8 million, both highlighted as evidence of progress toward the company’s cash-flow-focused 2026 plan.
Fixed Cost Reductions and Expense Discipline
Management implemented headcount reductions and vendor consolidations expected to reduce fixed operating costs by approximately $30 million in 2026 (~20% reduction vs. 2025); non-GAAP total operating expenses (ex-SBC and restructuring) declined 21% to $82.3 million.
Product & Operating-Model Initiatives Launched
Company prepared and launched its lifetime advisory model and introduced final expense insurance in April; new agent-facing tech tools (member dashboard, system recommendations, dynamic scripts) are intended to drive retention and cross-sell.
Improved Lifetime Values Across Products
First quarter lifetime values increased: Medicare Advantage +3%, Medicare Supplement +19%, PDP +78%, supporting the case for higher-quality enrollments and cross-sell economics.
Strong Balance Sheet and Growing Commission Receivable
Cash, cash equivalents and short-term marketable securities totaled $110.8 million at quarter-end; commission receivable value grew to just over $1.0 billion, a 12% increase YoY (from $923 million).
3-Year Targets Toward Profitability and Growth
Updated 3-year outlook targets a return to revenue growth in 2027 (mid-single-digit) and mid-teens growth in 2028, adjusted EBITDA margin expansion to ~20% by 2028, and breakeven or better free cash flow in 2027.

Ehealth (EHTH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EHTH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 12, 2026
2026 (Q2)
-0.84 / -
-1.256
May 06, 2026
2026 (Q1)
-0.13 / 0.21
-0.469144.35% (+0.68)
Feb 25, 2026
2025 (Q4)
2.88 / 2.58
3.16-18.29% (-0.58)
Nov 05, 2025
2025 (Q3)
-1.10 / -1.26
-1.3184.10% (+0.05)
Aug 06, 2025
2025 (Q2)
-1.22 / -1.26
-1.399.64% (+0.13)
May 07, 2025
2025 (Q1)
-0.52 / -0.47
-0.81542.45% (+0.35)
Feb 26, 2025
2024 (Q4)
2.46 / 3.16
1.456117.03% (+1.70)
Nov 06, 2024
2024 (Q3)
-1.37 / -1.32
-1.173-12.36% (-0.15)
Aug 07, 2024
2024 (Q2)
-1.09 / -1.39
-0.71-95.77% (-0.68)
May 07, 2024
2024 (Q1)
-0.69 / -0.81
-0.54-50.93% (-0.27)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EHTH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 06, 2026
$2.00$1.86-7.00%
Feb 25, 2026
$1.74$1.89+8.62%
Nov 05, 2025
$4.93$4.94+0.20%
Aug 06, 2025
$3.27$4.76+45.57%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ehealth (EHTH) report earnings?
Ehealth (EHTH) is schdueled to report earning on Aug 12, 2026, After Close (Confirmed).
    What is Ehealth (EHTH) earnings time?
    Ehealth (EHTH) earnings time is at Aug 12, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EHTH EPS forecast?
          EHTH EPS forecast for the fiscal quarter 2026 (Q2) is -0.84.